cas 2172875-14-6|| where to buy tert-butyl N-[1-(6-bromo-3-chloroquinolin-4-yl)piperidin-4-yl]carbamate

Produktname:tert-butyl N-[1-(6-bromo-3-chloroquinolin-4-yl)piperidin-4-yl]carbamate

IUPAC Name:tert-butyl N-[1-(6-bromo-3-chloroquinolin-4-yl)piperidin-4-yl]carbamate

: CAS：2172875-14-6; Molekulare Formel：C19H23BrClN3O2; Reinheit：95%+

Packungseinheit	Verfügbarer Vorrat	Preis($)	Menge

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 2172875-14-6 regularly via the above email.

Zusätzliche Hinweise

Verification code*

refresh

: CAS-Nr.:2172875-14-6; Molekulare Formel:C19H23BrClN3O2; Schmelzpunkt:-; SMILES-Code:CC(C)(C)OC(=O)NC1CCN(CC1)C1=C2C=C(Br)C=CC2=NC=C1Cl; Dichte:

: Katalognummer:CM1075011; Molekulargewicht:440.77; Siedepunkt:; Mdl-Nr.:; Lagerung:

: Quinolines; Quinolines are an important class of biologically active heterocyclic compounds, and their derivatives usually exhibit a variety of biological activities. They can be used as antimalarial drugs and in the preparation of other antimalarial drugs. Other important activities of quinoline derivatives include inhibitory activity against EGFR-TK and antipsychotic activity. Futhermore, quinoline scaffolds are present in various drug molecules, including the antimalarial drugs aablaquine, chloroquine, mefloquine and primaquine, and the antibacterial agents gatifloxacin, levofloxacin, and moxifloxacin.; Quinoline Price; if you have any question on quinoline price, we will give the professional answers to your short questions.

: Paltusotine; Crinetics’ once-daily oral paltusotine achieved the primary and all secondary endpoints in the phase 3 PATHFNDR-2 study in acromegaly patients.
Acromegaly is a serious rare disease generally caused by a pituitary adenoma, a benign tumor in the pituitary that secretes growth hormone (GH). Excess GH secretion causes excess secretion of IGF-1 from the liver. Prolonged exposure to increased levels of IGF-1 and GH leads to progressive and serious systemic complications, often resulting in bone, joint, cardiovascular, metabolic, cerebrovascular, or respiratory disease.
Paltusotine is the first oral, once-daily selectively-targeted somatostatin receptor type 2 (SST2) agonist and is currently in investigational Phase 3 studies for acromegaly and a Phase 2 study for carcinoid syndrome.